Ganciclovir

Pharm Company: * RANBAXY
Category: Antiviral

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Ganciclovir Overview

Ganciclovir is an antiviral medication used to treat cytomegalovirus (CMV) infections. A prodrug form with improved oral bioavailability (valganciclovir) has also been developed. Ganciclovir was approved for medical use in 1989.[1] Contents 1 Medical use 2 Adverse effects 2.1 Toxicity 3 Mechanism of action 4 Pharmacokinetics 4.1 Administration 5 References 5.1 Further reading Medical use Ganciclovir is indicated for:[2] Sight-threatening CMV ...

Read more Ganciclovir Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ganciclovir

Recent Ganciclovir Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ganciclovir
  • Capsule: 250mg, 500mg
  • Gel: 0.15%
  • Implant: 4.5mg
  • Injection: 2mg/ml, 500mg, 500mg/vial
  • Solution: 500mg/250ml (2mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ganciclovir: (12 results)

Sorted by National Drug Code
  • 0004-6940 Cytovene 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Genentech, Inc.
  • 14335-030 Ganciclovir 50 mg/ml Intraventricular Injection, Powder, Lyophilized, for Solution by Hainan Poly Pharm. Co., Ltd.
  • 25021-185 Ganciclovir 50 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 42023-173 Ganciclovir 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Par Pharmaceutical, Inc.
  • 51754-2500 Ganciclovir 2 mg/ml Intravenous Injection, Solution by Exela Pharma Sciences, LLC
  • 51817-171 Ganciclovir 500 mg/10ml Intravenous Injection, Solution by Pharmascience Inc.
  • 55390-016 Ganciclovir 50 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Bedford Laboratories
  • 63304-636 Ganciclovir 250 mg/1 Oral Capsule by Ranbaxy Pharmaceuticals Inc.
  • 63304-637 Ganciclovir 500 mg/1 Oral Capsule by Ranbaxy Pharmaceuticals Inc.
  • 63323-315 Ganciclovir 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by App Pharmaceuticals, LLC
  • 69292-015 Ganciclovir 1.5 mg/g Ophthalmic Gel by Amici Pharmaceuticals LLC
  • 70436-089 Ganciclovir 50 mg/ml Intraventricular Injection, Powder, Lyophilized, for Solution by Slate Run Pharmaceuticals

Other drugs which contain Ganciclovir or a similar ingredient: (5 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA